Design of Experiments Approach to Engineer Cell-secreted Matrices for Directing Osteogenic Differentiation

Overview

Journal Ann Biomed Eng

Specialty Biomedical Engineering

Date 2010 Dec 2

PMID 21120695

Citations 37

Authors

Martin L Decaris

J Kent Leach

Affiliations

Soon will be listed here.

Abstract

The presentation of extracellular matrix (ECM) proteins provides an opportunity to instruct the phenotype and behavior of responsive cells. Decellularized cell-secreted matrix coatings (DM) represent a biomimetic culture surface that retains the complexity of the natural ECM. Microenvironmental culture conditions alter the composition of these matrices and ultimately the ability of DMs to direct cell fate. We employed a design of experiments (DOE) multivariable analysis approach to determine the effects and interactions of four variables (culture duration, cell seeding density, oxygen tension, and media supplementation) on the capacity of DMs to direct the osteogenic differentiation of human mesenchymal stem cells (hMSCs). DOE analysis revealed that matrices created with extended culture duration, ascorbate-2-phosphate supplementation, and in ambient oxygen tension exhibited significant correlations with enhanced hMSC differentiation. We validated the DOE model results using DMs predicted to have superior (DM1) or lesser (DM2) osteogenic potential for naïve hMSCs. Compared to cells on DM2, hMSCs cultured on DM1 expressed 2-fold higher osterix levels and deposited 3-fold more calcium over 3 weeks. Cells on DM1 coatings also exhibited greater proliferation and viability compared to DM2-coated substrates. This study demonstrates that DOE-based analysis is a powerful tool for optimizing engineered systems by identifying significant variables that have the greatest contribution to the target output.

Citing Articles

Macromolecular crowding and decellularization method increase the growth factor binding potential of cell-secreted extracellular matrices.

Fok S, Gresham R, Ryan W, Osipov B, Bahney C, Leach J Front Bioeng Biotechnol. 2023; 11:1091157.

PMID: 36756385 PMC: 9899907. DOI: 10.3389/fbioe.2023.1091157.

Development of a fibrin-mediated gene delivery system for the treatment of cystinosis via design of experiment.

Graceffa V Sci Rep. 2022; 12(1):3752.

PMID: 35260693 PMC: 8904479. DOI: 10.1038/s41598-022-07750-y.

Engineered Cell-Secreted Extracellular Matrix Modulates Cell Spheroid Mechanosensing and Amplifies Their Response to Inductive Cues for the Formation of Mineralized Tissues.

Gonzalez-Fernandez T, Tenorio A, Saiz Jr A, Leach J Adv Healthc Mater. 2021; 11(10):e2102337.

PMID: 34968011 PMC: 9117430. DOI: 10.1002/adhm.202102337.

Clever Experimental Designs: Shortcuts for Better iPSC Differentiation.

Yasui R, Sekine K, Taniguchi H Cells. 2021; 10(12).

PMID: 34944048 PMC: 8700474. DOI: 10.3390/cells10123540.

Growth factor delivery using extracellular matrix-mimicking substrates for musculoskeletal tissue engineering and repair.

Gresham R, Bahney C, Leach J Bioact Mater. 2021; 6(7):1945-1956.

PMID: 33426369 PMC: 7773685. DOI: 10.1016/j.bioactmat.2020.12.012.

References

Liao J, Guo X, Nelson D, Kasper F, Mikos A . Modulation of osteogenic properties of biodegradable polymer/extracellular matrix scaffolds generated with a flow perfusion bioreactor. Acta Biomater. 2010; 6(7):2386-93. PMC: 2874124. DOI: 10.1016/j.actbio.2010.01.011. View

Lecanda F, Avioli L, Cheng S . Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem. 1997; 67(3):386-96. View

Cool S, Nurcombe V . Substrate induction of osteogenesis from marrow-derived mesenchymal precursors. Stem Cells Dev. 2006; 14(6):632-42. DOI: 10.1089/scd.2005.14.632. View

Kim S, Lee G . Development of serum-free medium supplemented with hydrolysates for the production of therapeutic antibodies in CHO cell cultures using design of experiments. Appl Microbiol Biotechnol. 2009; 83(4):639-48. DOI: 10.1007/s00253-009-1903-1. View

Kundu A, Putnam A . Vitronectin and collagen I differentially regulate osteogenesis in mesenchymal stem cells. Biochem Biophys Res Commun. 2006; 347(1):347-57. DOI: 10.1016/j.bbrc.2006.06.110. View

Chen X, Dusevich V, Feng J, Manolagas S, Jilka R . Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res. 2007; 22(12):1943-56. DOI: 10.1359/jbmr.070725. View

He J, Genetos D, Yellowley C, Leach J . Oxygen tension differentially influences osteogenic differentiation of human adipose stem cells in 2D and 3D cultures. J Cell Biochem. 2010; 110(1):87-96. DOI: 10.1002/jcb.22514. View

Zahed M, Abdul Aziz H, Hasnain Isa M, Mohajeri L, Mohajeri S . Optimal conditions for bioremediation of oily seawater. Bioresour Technol. 2010; 101(24):9455-60. DOI: 10.1016/j.biortech.2010.07.077. View

Guilak F, Cohen D, Estes B, Gimble J, Liedtke W, Chen C . Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell. 2009; 5(1):17-26. PMC: 2768283. DOI: 10.1016/j.stem.2009.06.016. View

10.

Mauney J, Kaplan D, Volloch V . Matrix-mediated retention of osteogenic differentiation potential by human adult bone marrow stromal cells during ex vivo expansion. Biomaterials. 2004; 25(16):3233-43. DOI: 10.1016/j.biomaterials.2003.10.005. View

11.

Dennis J, Haynesworth S, Young R, Caplan A . Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant. 1992; 1(1):23-32. DOI: 10.1177/096368979200100106. View

12.

Badylak S, Gilbert T . Immune response to biologic scaffold materials. Semin Immunol. 2007; 20(2):109-16. PMC: 2605275. DOI: 10.1016/j.smim.2007.11.003. View

13.

Shah M, Pathak K . Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design. AAPS PharmSciTech. 2010; 11(2):489-96. PMC: 2902350. DOI: 10.1208/s12249-010-9414-z. View

14.

Jaiswal N, Haynesworth S, Caplan A, Bruder S . Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997; 64(2):295-312. View

15.

Mauney J, Kirker-Head C, Abrahamson L, Gronowicz G, Volloch V, Kaplan D . Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. J Biomed Mater Res A. 2006; 79(3):464-75. DOI: 10.1002/jbm.a.30876. View

16.

Griffiths L, Choe L, Reardon K, Dow S, Orton E . Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials. 2008; 29(26):3514-20. PMC: 2518324. DOI: 10.1016/j.biomaterials.2008.05.006. View

17.

Chen X . Extracellular matrix provides an optimal niche for the maintenance and propagation of mesenchymal stem cells. Birth Defects Res C Embryo Today. 2010; 90(1):45-54. DOI: 10.1002/bdrc.20171. View

18.

Decaris M, Lee C, Yoder M, Tarantal A, Leach J . Influence of the oxygen microenvironment on the proangiogenic potential of human endothelial colony forming cells. Angiogenesis. 2009; 12(4):303-11. PMC: 2778716. DOI: 10.1007/s10456-009-9152-6. View

19.

Dahl S, Koh J, Prabhakar V, Niklason L . Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant. 2003; 12(6):659-66. View

20.

Chen W, Likhitpanichkul M, Ho A, Simmons C . Integration of statistical modeling and high-content microscopy to systematically investigate cell-substrate interactions. Biomaterials. 2009; 31(9):2489-97. DOI: 10.1016/j.biomaterials.2009.12.002. View